Physician profile
Eric Shulman
NPI 1598008559
$17,801.17
in general payments reported to CMS, 2019-2025
21 companies · $1,941 in 2025
The $1,941 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,497 · 2022: $2,182 · 2023: $5,077 · 2024: $6,105 · 2025: $1,941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,805 · Travel and Lodging: $5,184 · Consulting Fee: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,804.91 |
| Travel and Lodging | $5,184.00 |
| Consulting Fee | $133.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,076.47 | 2021-2025 | Aveir, Ensite, Jot Dx |
| Medtronic, INC. | $2,033.42 | 2021-2024 | Micra, Azure Xt Dr Mri Surescan, Attain Command + Surevalve |
| Medical Device Business Services, INC. | $1,933.21 | 2023-2024 | Carto 3 |
| Boston Scientific Corporation | $1,796.13 | 2021-2025 | Rhythmia Mapping System, Farapulse, Watchman |
| Biotronik INC. | $1,435.78 | 2021-2025 | Acticor 7 Vr-T Dx, Selectra, Biomonitor |
| Biosense Webster, INC. | $1,328.13 | 2021-2024 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Janssen Pharmaceuticals, INC | $668.62 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $319.89 | 2022-2024 | Eliquis |
| Pfizer INC. | $279.86 | 2021-2024 | |
| Edwards Lifesciences Corporation | $152.05 | 2025 | Pascal |
| Elite Orthopedics, LLC | $137.77 | 2022 | |
| Sanofi-Aventis U.S. LLC | $134.99 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $116.78 | 2025 | Opsumit, Uptravi |
| Abiomed | $95.47 | 2024 | Impella |
| Cardiva Medical, INC. | $84.11 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.64 | 2021-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $39.66 | 2022-2024 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $37.97 | 2025 | Optimizer |
| Cvrx, INC. | $26.06 | 2025 | Barostim Neo System |
| Heartflow, INC. | $24.99 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.17 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shulman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.